secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2026-01-21T23:59:59+00:00
Accession:  0001193125-26-018094
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ALX Oncology increases inducement plan share reserve by 1.3M shares to total 2.8M shares
--------------------------------------------------------------------------------

- Board amended 2025 Inducement Equity Incentive Plan to reserve an additional 1,300,000 shares of common stock.
- Total shares reserved under the inducement plan now 2,800,000.
- Amendment adopted without stockholder approval per Nasdaq inducement award exception rules.
- Awards under the plan will be granted only to new employees as material inducement to join the Company.
- Plan terms are substantially similar to the Amended and Restated 2020 Equity Incentive Plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000119312526018094/0001193125-26-018094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000119312526018094/alxo-20260121.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-018094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer